Literature DB >> 14649565

Assessment of nutritional status and fluid deficits in advanced cancer.

Nabeel Sarhill1, Fade Aziz Mahmoud, Richard Christie, Adnan Tahir.   

Abstract

Malnutrition and cachexia are frequent manifestations of cancer and are major contributors to morbidity and mortality. The assessment of nutrition status in cancer patients can be easily accomplished. The first step is to record a complete medical history and to perform a thorough clinical examination to uncover signs of nutritional deficiency. Simple and inexpensive tests are available to assess the body composition, such as: anthropometric measurements, skinfold thickness, arm muscle circumference and area, and weight and body mass index (BMI). Biochemical measurements are also available, such as serum albumin, transferring, and prealbumin. Fluid deficit is divided into two categories based on pathophysiology (dehydration and volume depletion) and to three subtypes based on plasma sodium concentration (hyponatremic, hypernatremic, and isotonic). Dehydration (total water deficit, especially intracellular) is always hypernatremic, while volume depletion (intravascular water and sodium deficit) is either hyponatremic, hypernatremic, or isotonic. There are no clear clinical differences among the various categories, but a delay of capillary refill, tachycardia, and orthostatic hypotension is more common with volume depletion. Careful clinical assessment and laboratory tests, especially serum sodium, are the keystones for diagnosis and effective management. Bioelectrical impedance (BEI) is an easy way to assess both nutrition status and fluid deficits in advanced cancer and should be used more often than it currently is. This article reviews the subjective and objective methods of assessing fluid deficit and nutrition in advanced cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14649565     DOI: 10.1177/104990910302000610

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  16 in total

1.  ["Terminal" dehydration, part 2 : Medical indications and therapeutic approach].

Authors:  U Suchner; C Reudelsterz; C Gog
Journal:  Anaesthesist       Date:  2018-11       Impact factor: 1.041

2.  A bioimpedance analysis of head-and-neck cancer patients undergoing radiotherapy.

Authors:  K Kohli; R Corns; K Vinnakota; P Steiner; C Elith; D Schellenberg; W Kwan; A Karvat
Journal:  Curr Oncol       Date:  2018-06-28       Impact factor: 3.677

3.  Serum albumin, but not glycated albumin was a potent factor affecting the performance of GFR equation based on serum creatinine.

Authors:  Masaru Horio; Enyu Imai; Yoshinari Yasuda; Tsuyoshi Watanabe; Hitoshi Yokoyama; Hirofumi Makino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2014-06-07       Impact factor: 2.801

4.  Descriptive analysis of clinical factors affecting terminally ill cancer patients.

Authors:  A M Jiménez-Gordo; J Feliu; B Martínez; J de-Castro; N Rodríguez-Salas; N Sastre; Y Vilches; E Espinosa; J R Rodríguez-Aizcorbe; M González-Barón
Journal:  Support Care Cancer       Date:  2008-06-05       Impact factor: 3.603

Review 5.  How to manage terminal dehydration.

Authors:  U Suchner; C Reudelsterz; C Gog
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

6.  Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients.

Authors:  Tora S Solheim; Peter M Fayers; Torill Fladvad; Ben Tan; Frank Skorpen; Kenneth Fearon; Vickie E Baracos; Pål Klepstad; Florian Strasser; Stein Kaasa
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-04-26       Impact factor: 12.910

7.  Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C.

Authors:  Alisan Kahraman; Johannes Hilsenbeck; Monika Nyga; Judith Ertle; Alexander Wree; Mathias Plauth; Guido Gerken; Ali E Canbay
Journal:  Virol J       Date:  2010-08-16       Impact factor: 4.099

Review 8.  Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature.

Authors:  Digant Gupta; Christopher G Lis
Journal:  Nutr J       Date:  2010-12-22       Impact factor: 3.271

9.  Is there a genetic cause for cancer cachexia? - a clinical validation study in 1797 patients.

Authors:  T S Solheim; P M Fayers; T Fladvad; B Tan; F Skorpen; K Fearon; V E Baracos; P Klepstad; F Strasser; S Kaasa
Journal:  Br J Cancer       Date:  2011-09-20       Impact factor: 7.640

10.  Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer.

Authors:  Digant Gupta; Carolyn A Lammersfeld; Pankaj G Vashi; Jessica King; Sadie L Dahlk; James F Grutsch; Christopher G Lis
Journal:  BMC Cancer       Date:  2009-01-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.